2v2x: Difference between revisions

Revision as of 17:22, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2v2x.png

Template:STRUCTURE 2v2x

T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.

Template:ABSTRACT PUBMED 15583017

About this StructureAbout this Structure

2V2X is a Protein complex structure of sequences from Homo sapiens. This structure supersedes the now removed PDB entry 2bsv. Full crystallographic information is available from OCA.

ReferenceReference

T cell cross-reactivity and conformational changes during TCR engagement., Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, Douek DC, van der Merwe PA, Jones EY, McMichael AJ, J Exp Med. 2004 Dec 6;200(11):1455-66. PMID:15583017

Page seeded by OCA on Mon Jul 28 17:21:52 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2v2x.jpg|left|200px]]
+{{Seed}}
+[[Image:2v2x.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2v2x|  PDB=2v2x  |  SCENE=  }}
-'''T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.'''
+===T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.===
-==Overview==
+<!--
-All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition, which enables virus escape from immune control by mutation in infections such as the human immunodeficiency virus (HIV). To address this paradox, we analyzed the fine specificity of T cells recognizing a human histocompatibility leukocyte antigen (HLA)-A2-restricted, strongly immunodominant, HIV gag epitope (SLFNTVATL). The majority of 171 variant peptides tested bound HLA-A2, but only one third were recognized. Surprisingly, one recognized variant (SLYNTVATL) showed marked differences in structure when bound to HLA-A2. T cell receptor (TCR) recognition of variants of these two peptides implied that they adopted the same conformation in the TCR-peptide-major histocompatibility complex (MHC) complex. However, the on-rate kinetics of TCR binding were identical, implying that conformational changes at the TCR-peptide-MHC binding interface occur after an initial permissive antigen contact. These findings have implications for the rational design of vaccines targeting viruses with unstable genomes.
+The line below this paragraph, {{ABSTRACT_PUBMED_15583017}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 15583017 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_15583017}}
 ==About this Structure==
@@ Line 45: / Line 49: @@
 [[Category: Transmembrane]]
 [[Category: Ubl conjugation]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 18:07:29 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:21:52 2008''